GILD

135.93

3.65% 4.79

시간 외 거래: 135.81 -0.12 -0.09%

길리어드 사이언스 (GILD)

개요 뉴스 가격 이력 옵션 체인 Financials GILD 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$131.14

열려 있는:

$131.26

하루 거래량:

13.18M

Relative Volume:

1.92

시가총액:

$168.65B

수익:

$29.05B

순이익/손실:

$8.11B

주가수익비율:

21.05

EPS:

6.4563

순현금흐름:

$9.16B

1주 성능:

+8.82%

1개월 성능:

+8.58%

6개월 성능:

+19.70%

1년 성능:

+46.29%

1일 변동 폭

$131.00

$136.30

1주일 범위

$122.28

$136.30

52주 변동 폭

$92.26

$136.30

길리어드 사이언스 Stock (GILD) Company Profile

명칭

Gilead Sciences Inc

부문

Healthcare (1112)

산업

Drug Manufacturers - General (19)

전화

(650) 574-3000

주소

333 LAKESIDE DR, FOSTER CITY, CA

직원

17,600

트위터

@GileadSciences

다음 수익 날짜

2025-02-11

최신 SEC 제출 서류

GILD's Discussions on Twitter

GILD을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
GILD Gilead Sciences Inc	135.93	162.70B	29.05B	8.11B	9.16B	6.4563
LLY Lilly Eli Co	1,064.29	973.23B	59.42B	18.41B	6.44B	20.22
JNJ Johnson Johnson	220.14	526.41B	94.19B	26.80B	20.46B	11.05
ABBV Abbvie Inc	219.26	385.48B	59.64B	2.36B	19.68B	1.3253
NVS Novartis Ag Adr	147.14	278.22B	54.45B	14.42B	17.15B	7.333
NVO Novo Nordisk Adr	62.26	276.52B	46.69B	15.29B	9.25B	3.4329

길리어드 사이언스 Stock (GILD) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-01-07	재개	UBS	Buy
2025-11-24	재개	Truist	Buy
2025-11-13	개시	Scotiabank	Sector Outperform
2025-08-19	업그레이드	Daiwa Securities	Neutral → Outperform
2025-08-08	업그레이드	Truist	Hold → Buy
2025-07-25	업그레이드	Needham	Hold → Buy
2025-04-22	재개	Cantor Fitzgerald	Overweight
2025-03-04	재확인	Oppenheimer	Outperform
2025-02-18	업그레이드	Deutsche Bank	Hold → Buy
2025-02-13	업그레이드	DZ Bank	Hold → Buy
2025-01-10	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	재개	BofA Securities	Buy
2024-11-15	개시	Wolfe Research	Outperform
2024-11-14	개시	Citigroup	Buy
2024-11-08	다운그레이드	Maxim Group	Buy → Hold
2024-10-21	업그레이드	Leerink Partners	Market Perform → Outperform
2024-10-17	개시	Bernstein	Outperform
2024-10-07	업그레이드	Wells Fargo	Equal Weight → Overweight
2024-07-08	업그레이드	Raymond James	Mkt Perform → Outperform
2024-05-01	재확인	Maxim Group	Buy
2024-04-24	업그레이드	HSBC Securities	Reduce → Hold
2024-02-22	다운그레이드	Truist	Buy → Hold
2023-11-09	개시	Deutsche Bank	Hold
2023-09-08	업그레이드	BofA Securities	Neutral → Buy
2023-09-06	개시	HSBC Securities	Reduce
2023-07-24	재확인	Barclays	Equal Weight
2023-05-16	업그레이드	BMO Capital Markets	Market Perform → Outperform
2023-04-28	재개	Piper Sandler	Overweight
2023-01-03	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2022-12-13	재개	BofA Securities	Neutral
2022-12-09	다운그레이드	DZ Bank	Buy → Hold
2022-10-31	업그레이드	Barclays	Underweight → Equal Weight
2022-10-28	재확인	BMO Capital Markets	Market Perform
2022-10-28	재확인	Cowen	Outperform
2022-10-28	재확인	JP Morgan	Overweight
2022-10-28	재확인	Jefferies	Buy
2022-10-28	업그레이드	Piper Sandler	Neutral → Overweight
2022-10-28	재확인	RBC Capital Mkts	Outperform
2022-10-28	업그레이드	Truist	Hold → Buy
2022-10-28	재확인	Wells Fargo	Equal Weight
2022-10-04	업그레이드	JP Morgan	Neutral → Overweight
2022-07-13	개시	Cantor Fitzgerald	Neutral
2022-05-23	개시	SVB Leerink	Mkt Perform
2022-02-28	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2022-02-02	재확인	BMO Capital Markets	Outperform
2022-02-02	재확인	BofA Securities	Neutral
2022-02-02	재확인	RBC Capital Mkts	Outperform
2022-02-02	재확인	Truist	Hold
2022-02-02	재확인	Wells Fargo	Equal Weight
2022-01-28	업그레이드	Argus	Hold → Buy
2022-01-06	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-12-09	재개	Wells Fargo	Equal Weight
2021-12-06	개시	Goldman	Neutral
2021-11-19	업그레이드	BMO Capital Markets	Market Perform → Outperform
2021-11-19	재개	Piper Sandler	Neutral
2021-10-20	재개	Cowen	Outperform
2021-07-30	재확인	BMO Capital Markets	Market Perform
2021-07-30	재확인	RBC Capital Mkts	Outperform
2021-04-01	업그레이드	Bernstein	Mkt Perform → Outperform
2021-03-30	업그레이드	Redburn	Neutral → Buy
2021-01-19	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2021-01-04	업그레이드	Guggenheim	Neutral → Buy
2020-11-03	재개	Morgan Stanley	Equal-Weight
2020-10-28	개시	UBS	Neutral
2020-09-30	재개	Jefferies	Buy
2020-09-15	업그레이드	Maxim Group	Hold → Buy
2020-07-31	재확인	Credit Suisse	Neutral
2020-07-31	재확인	Morgan Stanley	Equal-Weight
2020-07-31	재확인	Piper Sandler	Overweight
2020-07-31	재확인	RBC Capital Mkts	Outperform
2020-07-31	재확인	SunTrust	Hold
2020-07-31	재확인	Wells Fargo	Equal Weight
2020-07-20	업그레이드	Credit Suisse	Underperform → Neutral
2020-06-03	업그레이드	SVB Leerink	Mkt Perform → Outperform
2020-05-26	업그레이드	SunTrust	Sell → Hold
2020-05-01	다운그레이드	JP Morgan	Overweight → Neutral
2020-05-01	다운그레이드	Raymond James	Outperform → Mkt Perform
2020-05-01	다운그레이드	SunTrust	Hold → Sell
2020-04-27	다운그레이드	UBS	Buy → Neutral
2020-04-20	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2020-04-20	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-04-17	다운그레이드	CFRA	Hold → Sell

모두보기

길리어드 사이언스 주식(GILD)의 최신 뉴스

07:34 AM

Gilead Sciences, Inc. $GILD is Sector Gamma AS's 9th Largest Position - MarketBeat

07:34 AM

05:01 AM

First Citizens Bank & Trust Co. Purchases 61,959 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

05:01 AM

03:22 AM

AMF Tjanstepension AB Reduces Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

03:22 AM

Jan 24, 2026

Mn Services Vermogensbeheer B.V. Acquires 8,500 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jan 24, 2026

Gilead Sciences, Inc. $GILD Shares Sold by Resona Asset Management Co. Ltd. - MarketBeat

Jan 24, 2026

Gilead Sciences, Inc. $GILD Stake Increased by Mitsubishi UFJ Trust & Banking Corp - MarketBeat

Jan 24, 2026

UniSuper Management Pty Ltd Has $62.38 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Jan 24, 2026

Teacher Retirement System of Texas Has $36.91 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jan 24, 2026

Gilead Sciences, Inc. $GILD Shares Acquired by Envestnet Portfolio Solutions Inc. - MarketBeat

Jan 24, 2026

Gilead Sciences (NASDAQ:GILD) Downgraded by Wall Street Zen to Buy - MarketBeat

Jan 24, 2026

Jan 23, 2026

Gilead stock jumps again as Trodelvy-Keytruda breast cancer data lands in NEJM - TechStock²

Jan 23, 2026

Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch

Jan 23, 2026

Gilead stock jumps again as Trodelvy-Keytruda breast cancer data hit NEJM - TechStock²

Jan 23, 2026

MOKAN Wealth Management Inc. Trims Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jan 23, 2026

Strs Ohio Purchases 24,284 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jan 23, 2026

Rakuten Investment Management Inc. Purchases New Shares in Gilead Sciences, Inc. $GILD - MarketBeat

Jan 23, 2026

Grandfield & Dodd LLC Sells 20,655 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jan 23, 2026

iA Global Asset Management Inc. Raises Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jan 23, 2026

Jan 22, 2026

Movement Recap: Is Gilead Sciences Inc trading at a discount2025 Market Sentiment & Stepwise Trade Signal Guides - baoquankhu1.vn

Jan 22, 2026

Why Gilead Sciences (GILD) Outpaced the Stock Market Today - Yahoo Finance

Jan 22, 2026

4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer - GlobeNewswire Inc.

Jan 22, 2026

Gilead Sciences publishes Trodelvy-Keytruda data in NEJM - The Pharma Letter

Jan 22, 2026

Cell Therapy Market Dynamics and Contributions by Gilead - openPR.com

Jan 22, 2026

Gilead Sciences Inc. (NASDAQ:GILD) Passes the Caviar Cruise Quality Investing Screen - Chartmill

Jan 22, 2026

Jan 21, 2026

Jeffrey Bluestone Sells 5,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat

Jan 21, 2026

GILD: Gilead Sciences Reports Positive Results for Trodelvy and Keytruda Combo - GuruFocus

Jan 21, 2026

Gilead Sciences (NASDAQ:GILD) Reaches New 12-Month High After Analyst Upgrade - MarketBeat

Jan 21, 2026

Gilead Sciences stock hits all-time high at 128.71 USD By Investing.com - Investing.com Nigeria

Jan 21, 2026

Gilead Sciences stock hits all-time high at 128.71 USD - Investing.com

Jan 21, 2026

Rothschild & Co Redburn Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - MarketBeat

Jan 21, 2026

Gilead Sciences (GILD) Valuation Check After Recent Share Price Softness - Yahoo Finance

Jan 21, 2026

Universal Beteiligungs und Servicegesellschaft mbH Lowers Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jan 21, 2026

Migdal Insurance & Financial Holdings Ltd. Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat

Jan 21, 2026

Jan 20, 2026

US Stocks Recap: What is the PEG ratio of Gilead Sciences IncPrice Action & Precise Swing Trade Entry Alerts - baoquankhu1.vn

Jan 20, 2026

Gilead Sciences: Margin Expansion And Cash Flow Strength Underpriced (NASDAQ:GILD) - Seeking Alpha

Jan 20, 2026

The Truth About Gilead Sciences Inc: Why Everyone Is Suddenly Watching This Stock - AD HOC NEWS

Jan 20, 2026

Bernstein reiterates Outperform rating on Gilead stock with $135 price target - Investing.com

Jan 20, 2026

Gilead Sciences, Inc. $GILD Shares Acquired by Wealth Enhancement Advisory Services LLC - MarketBeat

Jan 20, 2026

Royal Bank Of Canada Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat

Jan 20, 2026

40 Under 40: Calvin Yan Ting Chan, Gilead Sciences - Medical Marketing and Media

Jan 20, 2026

Stocks Generating Improved Relative Strength: Gilead Sciences - Investor's Business Daily

Jan 20, 2026

Jan 19, 2026

Gilead Sciences Earnings Outlook: Key Points to Watch - Bitget

Jan 19, 2026

Lobbying Update: $30,000 of TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES INC. lobbying was just disclosed - Quiver Quantitative

Jan 19, 2026

Gilead Sciences Earnings Preview: What to Expect - Barchart.com

Jan 19, 2026

Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Jan 19, 2026

Allstate Corp Grows Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jan 19, 2026

Gilead Sciences (NASDAQ:GILD) Nasdaq Futures Spotlight Biopharma Scale - Kalkine Media

Jan 19, 2026

Jan 18, 2026

Csenge Advisory Group Has $2.38 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Jan 18, 2026

Campbell & CO Investment Adviser LLC Invests $1.40 Million in Gilead Sciences, Inc. $GILD - MarketBeat

Jan 18, 2026

Jan 17, 2026

Gilead Sciences, Inc. $GILD Shares Sold by QRG Capital Management Inc. - MarketBeat

Jan 17, 2026

Jan 16, 2026

HER2-Negative Metastatic Breast Cancer Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Genentech, AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene, Eisai - Barchart.com

Jan 16, 2026